The seed round was backed by Amadeus Capital Partners, Delin Ventures and Kindred Capital to fund the commercial launch of its manufacturing technology.
"Hundreds of clinical trials and a few recently marketed products have shown the revolutionary potential of CGTs. But this potential will never be realised unless we can remove the current bottleneck around scalable manufacturing. Ori Biotech has developed an innovative platform technology to facilitate scalable manufacturing that could eventually enable millions of patients to get access to the next generation of personalised medicines,"
The financing round was backed by Kindred Capital, Moneysupermarket Group, and VentureFounders.
"With £11m of growth capital we are now well‐positioned to expand our business and provide more clients with a simple way to maximise the interest income on their cash and at the same time become an increasingly valuable funding partner to our banks."
Kindred Capital led the seed round to support international expansion into North America and Europe.
"Healthy organizational cultures start with trust. Vault’s breakthrough platform helps to build trust by embedding empathy and transparency into innovative tools that people can use if they experience workplace misconduct. Vault gives employees total control over their privacy, information and reporting at precisely the moment they need it most."
